Comprehensive medication guide to Forfivo XL including estimated pricing, availability information, side effects, and how to find it in stock at your local pharmacy.
Estimated Insurance Pricing
$28 per fill for commercially insured patients using the Almatica manufacturer copay card (card covers up to $50 additional). Many large PBMs including Express Scripts exclude Forfivo XL from preferred formularies; generic bupropion XL is broadly covered at Tier 1–2 with $0–$15 copays.
Estimated Cash Pricing
$395–$566 retail for brand-name Forfivo XL 450 mg (30-day supply); as low as $132–$133 with a GoodRx coupon. Generic bupropion XL 300 mg + 150 mg (equivalent dose) costs $7–$20/month with discount programs.
Medfinder Findability Score
55/100
Summarize with AI
On this page
Forfivo XL is a brand-name prescription antidepressant manufactured by Almatica Pharma, containing bupropion hydrochloride in a 450 mg extended-release tablet taken once daily. It is the only commercially available single-tablet formulation of bupropion at the maximum approved 450 mg daily dose. The FDA first approved bupropion in 1985 under the Wellbutrin brand; Forfivo XL was developed specifically to provide the 450 mg dose in a single convenient tablet for patients who require this higher dose.
Forfivo XL is FDA-approved for the treatment of major depressive disorder (MDD) in adults. It is classified as an aminoketone antidepressant — an atypical class chemically distinct from SSRIs, SNRIs, and tricyclic antidepressants. Its primary mechanism is inhibition of norepinephrine and dopamine reuptake, which distinguishes it from the serotonin-focused action of most other common antidepressants.
A critical prescribing rule: Forfivo XL cannot be used to initiate bupropion therapy. Patients must first be stabilized on 300 mg/day of another bupropion formulation for at least 2 weeks before switching to Forfivo XL. Alternatively, patients already on 450 mg/day of another bupropion product can switch directly.
We have a 99% success rate finding medications, even during nationwide shortages.
Need this medication?
Forfivo XL works by inhibiting the reuptake transporters for dopamine (DAT) and norepinephrine (NET) in the brain. In plain terms, it slows the "recycling pumps" that pull these neurotransmitters back into neurons after they've been released, keeping more dopamine and norepinephrine available in the synaptic gap where they can continue to activate neighboring neurons. This classifies bupropion as an NDRI — norepinephrine-dopamine reuptake inhibitor.
Dopamine plays a key role in motivation, pleasure, and the brain's reward circuits. Norepinephrine is involved in alertness, energy, and stress response. By increasing both, Forfivo XL addresses the fatigue, anhedonia (inability to feel pleasure), and low motivation that are hallmarks of major depressive disorder. Unlike SSRIs, bupropion has minimal serotonin activity — which is why it doesn't cause the sexual side effects or weight gain commonly associated with SSRI treatment.
The "XL" (extended-release) formulation uses a specialized coating system that releases bupropion slowly over 24 hours, maintaining consistent blood levels with a single once-daily dose. This reduces the peak-and-trough fluctuations of immediate-release formulations and lowers the risk of side effects associated with high peak concentrations.
450 mg — extended-release tablet
One tablet once daily without regard to food. Swallow whole — do not crush, divide, or chew. Not for initial therapy; requires prior titration on another bupropion formulation.
Forfivo XL is moderately difficult to find in 2026. It is not on an active FDA or ASHP drug shortage list — the product is being manufactured and distributed. However, patients frequently report difficulty filling their prescriptions due to three overlapping barriers: major insurance formulary exclusions (Express Scripts removed it from its 2025 National Preferred Formulary), limited routine pharmacy stocking (most pharmacies don't keep it on shelves due to low prescription volume), and high retail prices ($395–$566/month) that are prohibitive without assistance.
Chain pharmacies typically need 3-5 business days to order Forfivo XL from their wholesaler. Independent pharmacies may order it more quickly. Mail-order pharmacies are an option for patients with insurance coverage. Most patients who struggle to find Forfivo XL have the alternative of switching to generic bupropion XL 300 mg + 150 mg — an equivalent dose at a fraction of the cost and available at virtually every pharmacy.
If you need help locating Forfivo XL near you, medfinder calls pharmacies in your area to check which ones have it in stock and can fill your prescription. Results are texted to you. It's a paid service designed to save you the time and frustration of calling pharmacies yourself.
Forfivo XL is not a controlled substance, which means any licensed prescriber with standard DEA registration can prescribe it — no special schedules or restrictions apply. This makes it accessible from a wider range of providers compared to controlled substances like ADHD stimulants.
Psychiatrists: Most common prescribers for Forfivo XL specifically, as it typically follows a titration process for MDD treatment.
Primary Care Physicians (PCPs): Family medicine doctors, internists, and general practitioners regularly prescribe bupropion for established patients.
Nurse Practitioners (NPs) and Physician Assistants (PAs): Can prescribe Forfivo XL in most U.S. states; PMHNPs are especially common prescribers.
Neurologists: May prescribe off-label for conditions with comorbid depression.
Forfivo XL can be prescribed via telehealth without an in-person visit, since it is not a controlled substance. Platforms like Talkiatry, Brightside Health, Done, and Teladoc Health commonly prescribe antidepressants including bupropion via video appointments. This makes Forfivo XL accessible even for patients in rural areas or those with difficulty accessing in-person care.
No. Forfivo XL (bupropion hydrochloride) is not a controlled substance. It is not classified under any DEA Schedule (I through V). This has several practical implications for patients and prescribers:
Any licensed prescriber with standard prescribing authority can write a Forfivo XL prescription — no special DEA registration required beyond the standard license.
Telehealth providers can prescribe Forfivo XL without the in-person visit requirements that apply to Schedule II controlled substances (like stimulants for ADHD).
There are no DEA-mandated refill limits. Standard pharmacy and state rules apply.
The prescription can be called in, faxed, or sent electronically — no handwritten or in-person prescription required.
Note: Bupropion (the active ingredient in Forfivo XL) can cause a false positive result on urine drug screens for amphetamines. If you are subject to drug testing, inform the testing authority that you take bupropion.
The following side effects occurred in ≥5% of patients in clinical trials at twice the placebo rate:
Dry mouth
Nausea
Insomnia (take in the morning to minimize)
Dizziness
Headache and pharyngitis
Agitation and anxiety
Tremor and palpitations
Sweating, tinnitus, myalgia, urinary frequency, rash
Decreased appetite (may cause modest weight loss)
Seizures (stop medication immediately; dose-dependent risk is higher at 450 mg)
Suicidal thoughts or behavior (black box warning for patients under 25)
Hypertension (monitor blood pressure regularly)
Manic or hypomanic episodes
Psychosis or hallucinations
Severe allergic reactions (hives, difficulty breathing, facial swelling — seek emergency care)
Know what you need? Skip the search.
Generic Bupropion XL (300 mg + 150 mg)
Same active ingredient (bupropion HCl), same total 450 mg daily dose in two tablets. Widely available at virtually all pharmacies; costs $7–$20/month with GoodRx — the most clinically equivalent and cost-effective alternative.
Aplenzin (Bupropion HBr 522 mg)
Bupropion hydrobromide salt formulation; pharmacokinetically equivalent to bupropion HCl 450 mg. FDA-approved for MDD and SAD. Brand-name only; manufacturer copay card can reduce cost to $0 for eligible patients.
Trintellix (Vortioxetine)
Serotonin modulator antidepressant for MDD with potential cognitive benefits; different mechanism from bupropion. Once daily (5–20 mg). May be suitable for patients who need an alternative antidepressant class.
Lexapro (Escitalopram)
SSRI antidepressant; FDA-approved for MDD and GAD. Generic widely available at very low cost. May cause sexual dysfunction and weight gain unlike bupropion, but is first-line for many patients.
Prefer Forfivo XL? We can find it.
MAOIs (phenelzine, tranylcypromine, isocarboxazid, selegiline)
majorContraindicated. Wait at least 14 days after stopping an MAOI before starting Forfivo XL, and 14 days after stopping Forfivo XL before starting an MAOI. Risk of hypertensive crisis and severe neurological reactions.
Linezolid / IV methylene blue
majorMAOI-like activity; contraindicated concurrent use with Forfivo XL due to risk of severe hypertensive or serotonergic reactions.
Other bupropion products (Wellbutrin, Zyban, Aplenzin)
majorContraindicated — combining bupropion products exceeds the safe dose and dramatically increases seizure risk.
Clopidogrel (Plavix) / Ticlopidine
majorCYP2B6 inhibitors that increase bupropion blood levels, raising seizure and side effect risk. Monitor closely; bupropion dose reduction may be needed.
Metoprolol (Lopressor, Toprol-XL)
moderateBupropion inhibits CYP2D6, significantly increasing metoprolol exposure. May cause bradycardia. Metoprolol dose reduction often needed.
SSRIs and SNRIs (fluoxetine, paroxetine, venlafaxine)
moderateBupropion inhibits CYP2D6, raising levels of many antidepressants. May increase side effects. Monitor closely; dose adjustments may be required.
Carbamazepine / Phenobarbital / Phenytoin
moderateCYP2B6 inducers that reduce bupropion blood levels, potentially decreasing antidepressant efficacy. Dose adjustment may be needed.
Alcohol (heavy use or abrupt discontinuation)
majorHeavy alcohol use increases seizure risk. Abrupt alcohol withdrawal while on bupropion is particularly dangerous. Minimize alcohol consumption during therapy.
Forfivo XL is a legitimate, FDA-approved antidepressant that offers the convenience of a single once-daily 450 mg bupropion tablet. For patients who have been titrated to the maximum bupropion dose and prefer a simplified regimen, it fills an important niche. However, its brand-name status at a unique dose makes it vulnerable to insurance exclusions and limited pharmacy stocking — creating real access challenges for patients who need it.
The most important practical takeaways for Forfivo XL patients in 2026: check your insurance formulary before filling (or before your prescriber sends the prescription), apply for the Almatica savings card if you have commercial insurance, and know that generic bupropion XL 300 mg + 150 mg is a clinically equivalent and far more accessible alternative at a fraction of the cost.
If you need to find Forfivo XL at a pharmacy near you, medfinder can help. We call pharmacies in your area to check which ones have your medication in stock and can fill your prescription. Simply provide your medication, dosage, and ZIP code — we handle the rest and text you the results.
Medfinder Editorial Standards
Our medication guides are researched and written to help patients make informed decisions. All content is reviewed for accuracy and updated regularly. Learn more about our standards
ChatGPT
Claude
Perplexity
Grok
Gemini